The pandemic has been a turning point for investment in life sciences—but what does this mean for investors as well as life sciences companies looking to find opportunity in the industry?
In their latest video, Cheryl Reicin, Chris Bornhorst and Mike Pedlow give a sneak peek on some of the topics from our upcoming life sciences webinar on Thursday, December 10, where they will unpack the current state of financing for life sciences companies, including:
- a trend for going public in the United States through the use of special purpose acquisition companies;
- how a number of Canadian companies conduct U.S. initial public offerings without listing in Canada and whether this is a worrisome trend;
- what advantages the multijurisdictional disclosure system provides to Canadian life sciences companies; and
- how the COVID-19 pandemic has highlighted the importance and role of life sciences companies now more than ever.
Play the teaser below and register for the webinar on December 10.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
